Table 1.
Age, median (IQR) | 68 (26–90) |
---|---|
Sex, n (%) | |
Female | 11 (25.6) |
Male | 32 (74.4) |
Pre-treatment staging, n (%) | |
T1, 2 | 4 (9.3) |
T3, 4 | 39 (90.7) |
N0 | 9 (20.9) |
N1, 2 | 34 (79.1) |
Stages I and II | 9 (7.0) |
Stage III | 34 (93.0) |
Post-treatment staging, n (%) | |
ypT1, 2 | 15 (34.9) |
ypT3, 4 | 22 (53.5) |
ypN0 | 29 (67.4) |
ypN1, 2 | 14 (32.5) |
Stage 0 | 5 (11.6) |
Stages I and II | 25 (58.1) |
Stage III | 13 (30.2) |